Comparisons Between Separately Conducted Clinical Trials: Letter to the Editor Regarding Dabbous O, Maru B, Jansen JP, Lorenzi M, Cloutier M, Guérin A, et al. Adv Ther (2019) 36(5)...

por Sandrock, Alfred W., Farwell, Wildon
Publicado 2019

Overall Disability Response Score: An integrated endpoint to assess disability improvement and worsening over time in patients with multiple sclerosis

por Chang, Ih, Kappos, Ludwig, Giovannoni, Gavin, Calabresi, Peter A, Sandrock, Alfred, Cheng, Wenting, Xiao, Shan, Riester, Katherine, Belachew, Shibeshih, Deykin, Aaron, Zhu, Bing
Publicado 2022

Measuring treatment response to advance precision medicine for multiple sclerosis

por Calabresi, Peter A., Kappos, Ludwig, Giovannoni, Gavin, Plavina, Tatiana, Koulinska, Irene, Edwards, Michael R., Kieseier, Bernd, de Moor, Carl, Sotirchos, Elias S., Fisher, Elizabeth, Rudick, Richard A., Sandrock, Alfred
Publicado 2021

Alzheimer disease neuropathology in a patient previously treated with aducanumab

por Plowey, Edward D., Bussiere, Thierry, Rajagovindan, Raj, Sebalusky, Jennifer, Hamann, Stefan, von Hehn, Christian, Castrillo-Viguera, Carmen, Sandrock, Alfred, Budd Haeberlein, Samantha, van Dyck, Christopher H., Huttner, Anita
Publicado 2022

COVID-19 in Patients with Multiple Sclerosis: Associations with Disease-Modifying Therapies

por Reder, Anthony T., Centonze, Diego, Naylor, Maria L., Nagpal, Anjali, Rajbhandari, Rajani, Altincatal, Arman, Kim, Michelle, Berdofe, Aaron, Radhakrishnan, Maha, Jung, Eunice, Sandrock, Alfred W., Smirnakis, Karen, Popescu, Catrinel, de Moor, Carl
Publicado 2021

Association of Serum Neurofilament Light Levels With Long-term Brain Atrophy in Patients With a First Multiple Sclerosis Episode

por Plavina, Tatiana, Singh, Carol M., Sangurdekar, Dipen, de Moor, Carl, Engle, Bob, Gafson, Arie, Goyal, Jaya, Fisher, Elizabeth, Szak, Suzanne, Kinkel, Revere P., Sandrock, Alfred W., Su, Ray, Kieseier, Bernd C., Rudick, Richard A.
Publicado 2020

Nusinersen initiated in infants during the presymptomatic stage of spinal muscular atrophy: Interim efficacy and safety results from the Phase 2 NURTURE study

por De Vivo, Darryl C., Bertini, Enrico, Swoboda, Kathryn J., Hwu, Wuh-Liang, Crawford, Thomas O., Finkel, Richard S., Kirschner, Janbernd, Kuntz, Nancy L., Parsons, Julie A., Ryan, Monique M., Butterfield, Russell J., Topaloglu, Haluk, Ben-Omran, Tawfeg, Sansone, Valeria A., Jong, Yuh-Jyh, Shu, Francy, Staropoli, John F., Kerr, Douglas, Sandrock, Alfred W., Stebbins, Christopher, Petrillo, Marco, Braley, Gabriel, Johnson, Kristina, Foster, Richard, Gheuens, Sarah, Bhan, Ishir, Reyna, Sandra P., Fradette, Stephanie, Farwell, Wildon
Publicado 2019